You are here

SPECIMEN INTEGRITY AND PERSONAL PRIVACY IN DRUG TESTING

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 8126
Amount: $44,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1988
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
60 Franklin St
Morristown, NJ 07960
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract

URINE TESTING FOR DRUGS OF ABUSE REQUIRES THAT FRESH AND UNADULTERATED SPECIMENS ARE OBTAINED, FOR WITHOUT THIS EVEN THE MOST SOPHISTICATED ASSAYS ARE OF NO VALUE. WITNESSED COLLECTION IS IMPRACTICAL AND VIOLATES PERSONAL PRIVACY. RECENTLY ISSUED FEDERAL GUIDELINES SPECIFY PROCEDURES TO DECREASE THE LIKELIHOOD OF SAMPLE TAMPERING, BUT THE METHODS PROPOSED HAVE SIGNIFICANT LIMITATIONS. AS AN ALTERNATIVE TO DIRECT VISUALIZATION, FRANKLIN DIAGNOSTICS INTENDS TO DEVELOP A TAMPER-PROOF URINE COLLECTION DEVICE THAT DOCUMENTS SAMPLE INTEGRITY, YET MINIMIZES THE INVASION OF AN INDIVIDUAL'S PRIVACY. THIS DEVICE WILL USE FRANKLIN'S URINARY THERMOMETER TECHNOLOGY TODEMONSTRATE FRESHNESS AND A VARIETY OF SOLID PHASE REAGENTS TO DETECT CHEMICAL AND ENZYMATIC ADULTERATION. BECAUSE A COLLECTING DEVICE THAT ENSURES SAMPLE INTEGRITY CURRENTLY DOES NOT EXIST, THE PROPOSED COLLECTOR REPRESENTS A SIGNIFICANT TECHNOLOGIC INNOVATION. ITS INTENDED USE IN DRUG TESTING, A LARGE AND GROWING MARKET, OFFERS A CLEAR COMMERCIAL OPPORTUNITY.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government